The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus
Open accessAbstract
CD19-targeted CAR T cells show sustained CD19 + B cell depletion and profound therapeutic benefit in ameliorating disease in mouse models of lupus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
Schuster, S. J., Svoboda, J., Chong, E. A., Nasta, S. D., Mato, A. R., Anak, Ö., Brogdon, J. L., Pruteanu-Malinici, I., Bhoj, V., Landsburg, D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1708566 · Cited by 1,860
Cohen, S. B., Emery, P., Greenwald, M. W., Dougados, M., Furie, R. A., Genovese, M. C., Keystone, E. C., Loveless, J. E., Burmester, G., Cravets, M. W., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22025 · Cited by 1,638
Rahman, A., & Isenberg, D. A. (2008) · New England Journal of Medicine · doi:10.1056/nejmra071297 · Cited by 1,632
Murine Models of Systemic Lupus Erythematosus
Theofilopoulos, A. N., & Dixon, F. J. (1985) · Advances in Immunology · doi:10.1016/s0065-2776(08)60342-9 · Cited by 1,550
Absolute Quantification of Proteins by LCMSE
Silva, J. C., Gorenstein, M. V., Li, G.-Z., Vissers, J. P. C., & Geromanos, S. J. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500230-mcp200 · Cited by 1,529
Merrill, J. T., Neuwelt, C. M., Wallace, D. J., Shanahan, J. C., Latinis, K. M., Oates, J. C., Utset, T. O., Gordon, C., Isenberg, D. A., Hsieh, H., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27233 · Cited by 1,409
Christensen, S. R., Shupe, J., Nickerson, K., Kashgarian, M., Flavell, R. A., & Shlomchik, M. J. (2006) · Immunity · doi:10.1016/j.immuni.2006.07.013 · Cited by 1,090
The Principles of Engineering Immune Cells to Treat Cancer
Lim, W. A., & June, C. H. (2017) · Cell · doi:10.1016/j.cell.2017.01.016 · Cited by 1,080
Rahman, M. U. (2008) · Essentials of Physical Medicine and Rehabilitation · doi:10.1016/b978-1-4160-4007-1.50153-x · Cited by 1,019
Le, R. Q., Li, L., Yuan, W., Shord, S. S., Nie, L., Habtemariam, B. A., Przepiorka, D., Farrell, A. T., & Pazdur, R. (2018) · The Oncologist · doi:10.1634/theoncologist.2018-0028 · Cited by 873
Looney, R. J., Anolik, J. H., Campbell, D., Felgar, R. E., Young, F., Arend, L. J., Sloand, J. A., Rosenblatt, J., & Sanz, I. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20430 · Cited by 776
Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease
Ellebrecht, C. T., Bhoj, V. G., Nace, A., Choi, E. J., Mao, X., Cho, M. J., Di Zenzo, G., Lanzavecchia, A., Seykora, J. T., Cotsarelis, G., et al. (2016) · Science · doi:10.1126/science.aaf6756 · Cited by 738
Pegram, H. J., Lee, J. C., Hayman, E. G., Imperato, G. H., Tedder, T. F., Sadelain, M., & Brentjens, R. J. (2012) · Blood · doi:10.1182/blood-2011-12-400044 · Cited by 678
Brentjens, R. J., Latouche, J.-B., Santos, E., Marti, F., Gong, M. C., Lyddane, C., King, P. D., Larson, S., Weiss, M., Rivière, I., et al. (2003) · Nature Medicine · doi:10.1038/nm827 · Cited by 669
Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation.
Shlomchik, M., Mascelli, M., Shan, H., Radic, M. Z., Pisetsky, D., Marshak-Rothstein, A., & Weigert, M. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.1.265 · Cited by 666
Self-citationLy-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies.
Hayakawa, K., Hardy, R. R., Honda, M., Herzenberg, L. A., Steinberg, A. D., & Herzenberg, L. A. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.8.2494 · Cited by 637
T memory stem cells in health and disease
Gattinoni, L., Speiser, D. E., Lichterfeld, M., & Bonini, C. (2017) · Nature Medicine · doi:10.1038/nm.4241 · Cited by 620
Manson, J. J., & Rahman, A. (2006) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-1-6 · Cited by 605
Drift time-specific collision energies enable deep-coverage data-independent acquisition proteomics
Distler, U., Kuharev, J., Navarro, P., Levin, Y., Schild, H., & Tenzer, S. (2014) · Nature Methods · doi:10.1038/nmeth.2767 · Cited by 481
Kochenderfer, J. N., Yu, Z., Frasheri, D., Restifo, N. P., & Rosenberg, S. A. (2010) · Blood · doi:10.1182/blood-2010-01-265041 · Cited by 391
Self-citationZhao, Y., Wang, Q. J., Yang, S., Kochenderfer, J. N., Zheng, Z., Zhong, X., Sadelain, M., Eshhar, Z., Rosenberg, S. A., & Morgan, R. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900447 · Cited by 293
Self-citationBhoj, V. G., Arhontoulis, D., Wertheim, G., Capobianchi, J., Callahan, C. A., Ellebrecht, C. T., Obstfeld, A. E., Lacey, S. F., Melenhorst, J. J., Nazimuddin, F., et al. (2016) · Blood · doi:10.1182/blood-2016-01-694356 · Cited by 276
Targeted antibody-mediated depletion of murine CD19 CAR T cells permanently reverses B cell aplasia
Paszkiewicz, P. J., Fräßle, S. P., Srivastava, S., Sommermeyer, D., Hudecek, M., Drexler, I., Sadelain, M., Liu, L., Jensen, M. C., Riddell, S. R., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84813 · Cited by 276
Cooper, L. J. N., Topp, M. S., Serrano, L. M., Gonzalez, S., Chang, W.-C., Naranjo, A., Wright, C., Popplewell, L., Raubitschek, A., Forman, S. J., et al. (2003) · Blood · doi:10.1182/blood-2002-07-1989 · Cited by 248
Depletion of B Cells in Murine Lupus: Efficacy and Resistance
Ahuja, A., Shupe, J., Dunn, R., Kashgarian, M., Kehry, M. R., & Shlomchik, M. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.3351 · Cited by 239
Peripheral blood B cell depletion after rituximab and complete response in lupus nephritis
Gomez Mendez, L. M., Cascino, M. D., Garg, J., Katsumoto, T. R., Brakeman, P., Dall’Era, M., Looney, R. J., Rovin, B., Dragone, L., & Brunetta, P. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01070118 · Cited by 188
Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice.
Jevnikar, A. M., Grusby, M. J., & Glimcher, L. H. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1137 · Cited by 188
Davila, M. L., Kloss, C. C., Gunset, G., & Sadelain, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061338 · Cited by 185
Local Renal Autoantibody Production in Lupus Nephritis
Espéli, M., Bökers, S., Giannico, G. A., Dickinson, H. A., Bardsley, V., Fogo, A. B., & Smith, K. G. C. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010050515 · Cited by 165
Pracht, K., Meinzinger, J., Daum, P., Schulz, S. R., Reimer, D., Hauke, M., Roth, E. A., Mielenz, D., Berek, C., Côrte‐Real, J., et al. (2017) · European Journal of Immunology · doi:10.1002/eji.201747019 · Cited by 158
The Physiologic Role of CD19 Cytoplasmic Tyrosines
Wang, Y., Brooks, S. R., Li, X., Anzelon-Mills, A. N., Rickert, R. C., & Carter, R. H. (2002) · Immunity · doi:10.1016/s1074-7613(02)00426-0 · Cited by 144
Differential Contribution of IL-4 and STAT6 vs STAT4 to the Development of Lupus Nephritis
Singh, R. R., Saxena, V., Zang, S., Li, L., Finkelman, F. D., Witte, D. P., & Jacob, C. O. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4818 · Cited by 141
Murine lupus in MRL/lpr mice lacking CD4 or CD8 T cells
Koh, D., Ho, A., Rahemtulla, A., Fung‐Leung, W., Griesser, H., & Mak, T. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250923 · Cited by 137
Activating systemic autoimmunity: B's, T's, and tolls
Shlomchik, M. J. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.08.005 · Cited by 132
Complement Factor H Deficiency Accelerates Development of Lupus Nephritis
Bao, L., Haas, M., & Quigg, R. J. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010060647 · Cited by 132
Marion, T. N., Bothwell, A. L. M., Briles, D. E., & Janeway, C. A. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.12.4269 · Cited by 130
Self-citationKrishnan, M. R., Wang, C., & Marion, T. N. (2012) · Kidney International · doi:10.1038/ki.2011.484 · Cited by 127
Self-citationTouma, Z., & Gladman, D. D. (2017) · Lupus Science & Medicine · doi:10.1136/lupus-2017-000239 · Cited by 112
Reddy, V. R., Cambridge, G., Isenberg, D. A., Glennie, M. J., Cragg, M. S., & Leandro, M. J. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39167 · Cited by 107
Bekar, K. W., Owen, T., Dunn, R., Ichikawa, T., Wang, W., Wang, R., Barnard, J., Brady, S. P., Nevarez, S., Goldman, B., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27515 · Cited by 105
Wang, Y., & Carter, R. H. (2005) · Immunity · doi:10.1016/j.immuni.2005.04.012 · Cited by 104
Long-Lived Plasma Cells in Autoimmunity: Lessons from B-Cell Depleting Therapy
Mahévas, M., Michel, M., Weill, J., & Reynaud, C. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00494 · Cited by 91
Contributions of B cells to lupus pathogenesis
Sang, A. L., Zheng, Y.-Y., & Morel, L. M. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.11.013 · Cited by 72
B Cell Depletion with Anti-CD79 mAbs Ameliorates Autoimmune Disease in MRL/ lpr Mice
Li, Y., Chen, F., Putt, M., Koo, Y., Madaio, M. P., Cambier, J. C., Cohen, P. L., & Eisenberg, R. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.2961 · Cited by 57
Hale, M. R., Rawlings, D. J., & Jackson, S. W. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.10.008 · Cited by 53
Wu, F., Zhang, W., Shao, H., Bo, H., Shen, H., Li, J., Liu, Y., Wang, T., Ma, W., & Huang, S. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.06.009 · Cited by 45
Ahuja, A., Teichmann, L. L., Wang, H., Dunn, R., Kehry, M. R., & Shlomchik, M. J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101629 · Cited by 41
Gallagher, S., Yusuf, I., McCaughtry, T. M., Turman, S., Sun, H., Kolbeck, R., Herbst, R., & Wang, Y. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39503 · Cited by 34
B-Cell Depletion — A Frontier in Monoclonal Antibodies for Multiple Sclerosis
Calabresi, P. A. (2016) · New England Journal of Medicine · doi:10.1056/nejme1614717 · Cited by 30
Bribes, E., Galiègue, S., Bourrié, B., & Casellas, P. (2003) · Immunology Letters · doi:10.1016/s0165-2478(02)00177-3 · Cited by 14
Hiepe, F., Alexander, T., & Voll, R. E. (2015) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-014-1438-4 · Cited by 10
Roldán, V., Marco, P., Fernández, C., et al. (2002) · PubMed · Cited by 7
Cited by
CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up
Müller, F., Taubmann, J., Bucci, L., Wilhelm, A., Bergmann, C., Völkl, S., Aigner, M., Rothe, T., Minopoulou, I., Tur, C., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2308917 · Cited by 1,095
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
Mackensen, A., Müller, F., Mougiakakos, D., Böltz, S., Wilhelm, A., Aigner, M., Völkl, S., Simon, D., Kleyer, A., Munoz, L., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-02017-5 · Cited by 1,092
Sun, L., Su, Y., Jiao, A., Wang, X., & Zhang, B. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01471-y · Cited by 1,014
CAR immune cells: design principles, resistance and the next generation
Labanieh, L., & Mackall, C. L. (2023) · Nature · doi:10.1038/s41586-023-05707-3 · Cited by 658
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
Mougiakakos, D., Krönke, G., Völkl, S., Kretschmann, S., Aigner, M., Kharboutli, S., Böltz, S., Manger, B., Mackensen, A., & Schett, G. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2107725 · Cited by 610
Metadata
- Authors
- Kansal, R., Richardson, N., Neeli, I., Khawaja, S., Chamberlain, D., Ghani, M., Ghani, Q.-U.-A., Balazs, L., Beranova-Giorgianni, S., Giorgianni, F., Kochenderfer, J. N., Marion, T., Albritton, L. M., & Radic, M.
- Venue
- Science Translational Medicine
- Published
- 2019-03-06
- Volume
- 11
- Issue
- 482
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2918633605
- Cited by
- 382
- References
- 52
- FWCI
- 21.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.